KSL-128114

N/A

Report date: 2023/03/27 17:44:16
NME

Base Information

Drug NameKSL-128114
Drug Alias NameKSL-128114
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSyndecan binding protein (Syntenin), isoform CRA_c inhibitors
TargetsSyndecan binding protein (Syntenin), isoform CRA_c
Therapy Area/IndicationsGlioblastoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Copenhagen
China Registration ClassN/A

Develop Information

Active CompaniesUniversity Of Copenhagen
Inactive CompaniesN/A
Active IndicationsGlioblastoma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A